| In millions, except per share items | Jun-25-22 | Mar-26-22 | Dec-25-21 | Sep-25-21 | Jun-26-21 | Mar-27-21 | Dec-26-20 | Sep-26-20 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Operating Activities | | | | | | | | |
| Net income | 1.2 | -0.1 | 23.8 | -86.1 | 35.6 | 45.3 | 21.8 | 34.4 |
| Depreciation and amortization | 9.0 | 10.7 | 10.5 | 7.9 | 9.8 | 9.8 | 9.9 | 8.5 |
| Unrealized foreign exchange loss | 3.9 | -3.1 | -0.5 | | | | | 0.4 |
| Stock-based compensation | 3.0 | 2.9 | 2.4 | 2.3 | 2.1 | 1.8 | 2.1 | 2.9 |
| Amortization of deferred debt issuance costs | 0.4 | 0.5 | 1.4 | 1.1 | 1.7 | 1.3 | 0.4 | 0.4 |
| Loss (gain) on disposal of assets | 2.0 | -0.4 | -22.4 | -1.7 | 0.5 | -8.7 | -33.1 | 32.9 |
| Provision for credit losses | 1.1 | 3.3 | 2.7 | 1.3 | 1.5 | 1.0 | 1.6 | 0.7 |
| Write-down of inventories | 0.7 | 3.6 | 5.7 | 3.9 | 2.8 | 2.3 | 5.9 | 1.5 |
| Net change in deferred taxes | -1.0 | 4.6 | 0.9 | -43.7 | 6.5 | -0.7 | 7.2 | 14.5 |
| Net cash impact from hedging activity | 0.3 | -2.5 | -2.7 | 0.8 | -1.9 | -3.1 | 4.2 | -4.5 |
| Other | -0.2 | -0.1 | | -0.1 | 0.6 | -0.7 | -0.2 | 0.2 |
| |
| Changes in assets and liabilities: | | | | | | | | |
| Accounts receivable | 2.5 | -1.8 | 0.2 | -1.6 | 5.8 | -0.4 | 16.4 | -0.8 |
| Inventories | -4.4 | -13.7 | 19.1 | -9.6 | -20.8 | -34.0 | -15.7 | -2.2 |
| Non-trade accounts receivable | -4.7 | -6.3 | 21.8 | -4.7 | 2.2 | -11.5 | 18.5 | -0.1 |
| Prepaid expenses | -4.7 | 1.0 | 5.2 | -7.5 | 2.1 | 0.6 | 1.8 | -3.8 |
| Other assets | -13.3 | 2.7 | 4.0 | -3.4 | 2.4 | -2.5 | -29.8 | 1.1 |
| Accounts payable and accrued liabilities | -22.9 | -27.4 | 25.8 | -13.0 | -11.4 | -12.7 | 11.4 | -1.9 |
| Income taxes payable | 4.5 | -14.5 | -3.3 | 15.7 | -17.0 | 2.5 | 21.6 | 1.0 |
| Other liabilities | 1.7 | -3.3 | -2.3 | -1.5 | -8.3 | -3.2 | 1.6 | -0.8 |
| Investing Activities | | | | | | | | |
| Capital expenditures | -9.6 | -6.0 | -10.0 | -7.8 | -9.9 | -7.4 | -7.1 | -6.4 |
| Proceeds from disposal of assets | 0.7 | 0.5 | 39.2 | -27.1 | 0.8 | 9.9 | 42.7 | 0.5 |
| Financing Activities | | | | | | | | |
| Term loan repayment | -159.8 | 23.0 | 101.2 | | 135.2 | -34.0 | -716.2 | 107.5 |
| Repayments of Long-term Lines of Credit | -159.8 | 23.0 | 101.2 | | 135.2 | -34.0 | -716.2 | 107.5 |
| Net increase in short-term debt | | | 406.4 | -44.8 | -17.2 | -32.4 | 100.3 | -82.5 |
| Debt issuance costs payment | | | -7.7 | -1.2 | -0.7 | -0.3 | -18.7 | |
| Common stock repurchase | | -75.0 | | -22.1 | | | | |
| Proceeds from exercise of stock options | | | | | | 0.5 | | |
| Net cash used in financing activities | -102.1 | 28.9 | 18.2 | 18.3 | -52.6 | -3.1 | -102.9 | -25.2 |
| |
| Discontinued Operations | | | | | | | | |
| Net change in cash, cash equivalents and restricted cash | -126.3 | -20.8 | 141.3 | 17.8 | -48.0 | 12.2 | -10.8 | 37.6 |